DRL Announces The Launch Of Anti-Allergy Drug In US Market
Dr. Reddy’s Laboratories Ltd. (DRL) has announced that it has launched Levocetirizine Dihydrochloride Tablets USP, 5 mg, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy 24HR Tablets, from UCB, in the US market as approved by the US FDA. The drug is an over-the-counter antihistamine used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing.
“This first-to-market launch for the store brand is the testament to the deep capabilities of our store brand OTC business,” said Mr. Milan Kalawadia, Vice President and Head, US Over-the-Counter and Speciality Rx businesses, DRL.
The Xyzal Allergy 24HR Tablets brand had US sales of approximately $71-mn for the most recent twelve months ending in January 2018.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
Best Service Pharmaceutical Producer CAS 2381089-83-2 Retatrutide 5mg Weight Loss Peptide
$70/MT FOB
2026-07-11
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The United States Lifts Restrictions on Ethane Exports to China, and Trade Relations Show Signs of Easing
-
Biden decided to raise tariffs on Chinese goods, US soybeans maybe face tariff adjustment challenges
-
U.S. agricultural supplies distributor CHS and West Central Ag Services sign merger intent
-
PPG launches strategic review: intends to sell North American architectural coatings business with annual revenue of nearly US$1.8 billion
-
The US chemical industry has had a tough profit season
-
Warm winter impact energy market US coal prices fell rapidly
-
The United States has released its annual update on Salmonella surveillance and testing at poultry producers across the country
-
Allergic rhinitis is back! Experts remind: early prevention and standardized treatment
-
How to Prevent Allergies?
-
Allergics? What Foods to Eat to Prevent Skin Allergies
Recommend Reading
-
Pfizer Warns Germany: Drug Pricing Could Put Investment at Risk
-
J&J VAT Dispute Threatens Free Medicine Access in Britain
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
-
Zydus Brings the First Keytruda Biosimilar Showdown to North America
-
Ascorbyl Palmitate: Properties, Uses, and Benefits
-
MTBE Market Prices Fluctuate Narrowly
-
In November, the Chinese marine fuel market trended downward with fluctuations
-
Methanol Market Trading Quiet
-
Since December, the Chinese phenol market has seen a significant decline